Centene Co. (NYSE:CNC) Shares Acquired by National Pension Service

National Pension Service lifted its stake in Centene Co. (NYSE:CNCFree Report) by 15.4% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,435,482 shares of the company’s stock after purchasing an additional 191,768 shares during the period. National Pension Service owned about 0.27% of Centene worth $108,063,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Park Place Capital Corp lifted its holdings in shares of Centene by 1,190.0% in the 3rd quarter. Park Place Capital Corp now owns 387 shares of the company’s stock valued at $29,000 after purchasing an additional 357 shares during the last quarter. WR Wealth Planners LLC boosted its holdings in Centene by 41.4% in the second quarter. WR Wealth Planners LLC now owns 468 shares of the company’s stock valued at $31,000 after acquiring an additional 137 shares during the last quarter. Chris Bulman Inc purchased a new position in Centene in the second quarter valued at about $33,000. Riverview Trust Co increased its position in shares of Centene by 154.6% during the second quarter. Riverview Trust Co now owns 527 shares of the company’s stock worth $35,000 after acquiring an additional 320 shares during the last quarter. Finally, Thurston Springer Miller Herd & Titak Inc. purchased a new stake in shares of Centene during the second quarter worth about $36,000. 93.63% of the stock is currently owned by hedge funds and other institutional investors.

Centene Trading Up 0.5 %

Shares of CNC opened at $63.82 on Tuesday. The company has a debt-to-equity ratio of 0.64, a current ratio of 1.10 and a quick ratio of 1.17. Centene Co. has a 1 year low of $59.77 and a 1 year high of $81.42. The company has a 50 day simple moving average of $70.97 and a two-hundred day simple moving average of $71.89. The firm has a market cap of $32.22 billion, a P/E ratio of 11.08, a price-to-earnings-growth ratio of 0.85 and a beta of 0.49.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on CNC. Wells Fargo & Company reduced their price objective on Centene from $91.00 to $90.00 and set an “overweight” rating for the company in a research report on Monday. Truist Financial decreased their price target on shares of Centene from $92.00 to $89.00 and set a “buy” rating for the company in a report on Monday, July 15th. Deutsche Bank Aktiengesellschaft increased their price target on shares of Centene from $82.00 to $87.00 and gave the stock a “hold” rating in a research report on Friday, August 2nd. Stephens reaffirmed an “equal weight” rating and set a $78.00 price objective on shares of Centene in a research note on Monday, August 5th. Finally, Jefferies Financial Group lowered shares of Centene from a “buy” rating to a “hold” rating and cut their target price for the stock from $83.00 to $69.00 in a report on Wednesday, July 24th. Seven investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $83.92.

View Our Latest Stock Report on Centene

About Centene

(Free Report)

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.

Further Reading

Institutional Ownership by Quarter for Centene (NYSE:CNC)

Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.